https://orcid.org/0000-0002-6728-3346
References
- McDonald GB. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology. 2010;51(4):1450–1460.
- Ivanov V, Faucher C, Bilger K, et al. Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL. Bone Marrow Transplant. 2003;32(9):961–963.
- Mohty M, Malard F, Abecassis M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51(7):906–912.
- Varma A, Abraham SC, Mehta RS, et al. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv. 2020;4(7):1296–1306.
- Hosoi H, Warigaya K, Murata S, et al. Refractory ascites with liver fibrosis developed in late phase allogeneic hematopoietic stem cell transplantation: report of three patients. Hematol Rep. 2016;8(2):6482.
- Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Semin Diagn Pathol. 2019;36(6):395–403.
- Guido M, Sarcognato S, Sacchi D, et al. Pathology of idiopathic non-cirrhotic portal hypertension. Virchows Arch. 2018;473(1):23–31.
- Guido M, Alves VAF, Balabaud C, International Liver Pathology Study Group, et al. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition. Histopathology. 2019;74(2):219–226.
- Schouten JN, Nevens F, Hansen B, et al. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther. 2012;35(12):1424–1433.
- Pai RK, van Besien K, Hart J, et al. Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant. Leuk. Lymphoma. 2012;53(8):1552–1557.
- De Bruyne R, Portmann B, Samyn M, et al. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol. 2006;44(2):407–410.
- Palomo M, Diaz-Ricart M, Carbo C, et al. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. Biol Blood Marrow Transplant. 2009;15(5):537–546.